Analgesics (Pharmacies) - Kenya

  • Kenya
  • Revenue in the Analgesics market is projected to reach US$61.19m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.44%, resulting in a market volume of US$79.75m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.09 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Kenya is experiencing significant growth and development.

Customer preferences:
Customers in Kenya have shown a growing preference for analgesics purchased from pharmacies. This preference can be attributed to several factors. Firstly, pharmacies are seen as reliable sources of medication, providing customers with assurance of quality and safety. Additionally, pharmacies offer convenience, with many located in easily accessible areas. Customers appreciate the ability to consult with pharmacists and receive personalized advice on the most suitable analgesic for their needs.

Trends in the market:
One notable trend in the Analgesics (Pharmacies) market in Kenya is the increasing demand for over-the-counter (OTC) analgesics. This trend can be attributed to the rising awareness among consumers about self-care and the availability of OTC analgesics for common ailments such as headaches and muscle pain. As a result, pharmacies are expanding their range of OTC analgesics to cater to this growing demand. Another trend in the market is the emergence of natural and herbal analgesics. Consumers in Kenya are increasingly seeking alternatives to conventional analgesics, driven by a growing interest in natural and holistic approaches to healthcare. Pharmacies are responding to this trend by stocking a wider range of natural and herbal analgesics, providing customers with more options to choose from.

Local special circumstances:
One of the key factors influencing the development of the Analgesics (Pharmacies) market in Kenya is the country's healthcare system. Kenya has a relatively high prevalence of certain health conditions such as malaria and HIV/AIDS, which can cause pain and discomfort. This creates a significant demand for analgesics, leading to the growth of the market. Additionally, the government of Kenya has implemented various healthcare initiatives, including the expansion of healthcare infrastructure and the promotion of affordable healthcare services. These initiatives have contributed to increased access to pharmacies and a higher demand for analgesics.

Underlying macroeconomic factors:
Several macroeconomic factors are driving the development of the Analgesics (Pharmacies) market in Kenya. Firstly, the country's population is growing at a rapid rate, leading to an increased demand for healthcare services, including analgesics. Additionally, Kenya's economy has been experiencing steady economic growth, resulting in higher disposable incomes and increased healthcare spending. This has enabled more consumers to afford analgesics and contribute to the growth of the market. Furthermore, the expansion of the middle class in Kenya has also played a role in driving the growth of the Analgesics (Pharmacies) market, as this demographic segment has higher purchasing power and is more likely to seek healthcare products from pharmacies. In conclusion, the Analgesics (Pharmacies) market in Kenya is developing due to customer preferences for reliable and convenient medication, trends towards OTC and natural analgesics, local special circumstances related to the healthcare system, and underlying macroeconomic factors such as population growth, economic development, and the expansion of the middle class.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)